Share Twitter LinkedIn Facebook Email Jennie Crews, MD, MMM, FACP, talks about how community oncology is interpreting and incorporating biomarkers into their immuno-oncology therapeutic choices
Edetek’s CONFORM Platform: Streamlining Clinical Data Management in Oncology Trials General 3 Mins Read
High-Dose Chemotherapy for Recurrent Germ Cell Tumors: ASCO 2024 Study Results – Hedyeh Ebrahimi, MD – City of Hope ASCO Annual Meeting 2 Mins Read
